The Singapore entity of Sydney-headquartered clinical research and testing company Novotech Health has allotted new shares worth $5 million to US-based NCGS Inc, according to corporate filings reviewed by DealStreetAsia – DATA VANTAGE.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
